Peptide Therapeutics Competitor Analysis Report - Global Forecast to 2025
The Global Peptide Therapeutics Market size was estimated at USD 24,461.45 Million in 2020 and expected to reach USD 27,134.60 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.96% to reach USD 41,146.68 Million by 2025.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Peptide Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
"Novartis International AG scored highest as a forefront vendor in FPNV Positioning Matrix for Peptide Therapeutics Market"
Forefront are rated highly by the users for product satisfaction and have substantially good business strategy scores. F-Forefront include Novartis International AG, Merck & Co., Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, and Teva Pharmaceutical Industries Ltd..
"Bachem Holding AG scored highest as a pathfinder and expected to the upcoming forefront in next couple of years"
Pathfinder have significant product satisfaction ratings but somehow lack business strategy as compared to forefronts and vitals. P-Pathfinder include Bachem Holding AG, AmbioPharm Inc., PolyPeptide Group, Novo Nordisk A/S, and Zealand Pharma A/S.
"Ipsen S.A. named as an upcoming vendor to watch in Peptide Therapeutics Market"
Niche solutions cater to the need of comparatively smaller segment of the overall market. They do not have the business strategy of the Forefront. They may have been rated positively on product satisfaction but have not yet received enough reviews to validate them. N-Niche include Ipsen S.A., CordenPharma International, and Hemmo Pharmaceuticals Pvt Ltd..
"Innovative offerings by Pfizer Inc. expected to increase its product satisfaction level for Peptide Therapeutics Market in upcoming years"
Vital have comparatively good business strategy but have not yet achieved the business strategy of the Forefront. However, they have low product satisfaction ratings. V-Vital include Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, GlaxoSmithKline PLC, Amgen Inc., and Eli Lilly and Company.
Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Peptide Therapeutics Market, including AmbioPharm Inc., Amgen Inc., AstraZeneca PLC, Bachem Holding AG, Bristol-Myers Squibb Company, CordenPharma International, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Hemmo Pharmaceuticals Pvt Ltd., Ipsen S.A., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., PolyPeptide Group, Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Zealand Pharma A/S.
Our reports have been used by over 10K customers, including:
Gliosarcoma (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Drugs In Development, 2021, provides an overview of the Gliosarcoma (Oncology) pipeline landscape.Gliosarcoma is a type of brain tumor that originates from glial...
Acute Lymphoblastic Leukemia Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Acute Lymphoblastic Leukemia Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Acute Lymphoblastic...
Cystic Fibrosis (CF) Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Cystic Fibrosis (CF) Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Cystic Fibrosis (CF) Therapeutics...
Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential...
Ovarian Cancer Diagnostics and Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Ovarian Cancer Diagnostics and Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Ovarian Cancer...
Report Scope: This report provides an update on BIO048C Biological Therapies for Cancer: Technologies and Global Markets.It reviews global markets for biologic therapeutics for cancer and forecasts trends for the use of biologics and cancer treatments through 2026. It discusses important biologics, market share by...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation. The global protein expression market is expected to grow from $2.01 billion in 2020 to $2.13 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth...
The global asthma therapeutics market reached a value of US$ 17.6 Billion in 2020. Looking forward, the market is expected to reach a value of US$ 19.13 Billion by 2026, expanding at a CAGR of 1.60% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
Stroke (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Drugs In Development, 2021, provides an overview of the Stroke (Cardiovascular) pipeline landscape.Stroke is a condition in which the brain cells suddenly die because...
630 pages •
By Roots Analysis Private Ltd.
• Aug 2021
INTRODUCTION Over the years, various technological advancements, such as antibody engineering for site-specific conjugation and enhanced pharmacokinetic and pharmacodynamic properties, have paved the way for antibody drug conjugates (ADCs) to be recognized as potent therapies targeting a wide range of indications, including...
Cancer Survival Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.